Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Therapeutic targets for medulloblastoma.

Wlodarski PK, Jozwiak J

Medical University of Warsaw, Center for Biostructure Research, Department of Histology and Embryology, Poland. pawel.wlodarski@am.edu.pl

BACKGROUND: Present treatment of medulloblastoma, the most common malignant brain tumor in children, includes surgery, radiotherapy and chemotherapy. In spite of radical treatment, only about 70% of patients survive. Also side effects of the treatment are severe, mostly due to applied radiotherapy. OBJECTIVE: The following review highlights potential molecular targets for pharmacotherapy of medulloblastoma, as well as the directions in which, in the authors' opinion, the field will evolve in near future. METHODS: Present literature on pathways engaged in formation of medulloblastoma is summarized in the context of their available pharmacological modulators. RESULTS: The quest for a better treatment modalities includes better risk stratification methods, including molecular profiling of individual tumors and a search for new small molecules capable of inhibiting hyperactive signaling pathways. Several candidates for such agents are being tested presently.

Published 19 March 2008 in Expert Opin Ther Targets, 12(4): 449-61.
Full-text of this article is available online (may require subscription).

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.